BR112014028589A2 - processo para fabricação de compostos de ciclopentilpirimidina hidroxilada - Google Patents

processo para fabricação de compostos de ciclopentilpirimidina hidroxilada

Info

Publication number
BR112014028589A2
BR112014028589A2 BR112014028589A BR112014028589A BR112014028589A2 BR 112014028589 A2 BR112014028589 A2 BR 112014028589A2 BR 112014028589 A BR112014028589 A BR 112014028589A BR 112014028589 A BR112014028589 A BR 112014028589A BR 112014028589 A2 BR112014028589 A2 BR 112014028589A2
Authority
BR
Brazil
Prior art keywords
manufacturing
hydroxylated
compounds
cyclopentylpyrimidine compounds
hydroxylated cyclopentylpyrimidine
Prior art date
Application number
BR112014028589A
Other languages
English (en)
Other versions
BR112014028589B1 (pt
Inventor
Gregory Sowell C
Han Chong
Askin David
W Lane Jonathan
l spencer Keith
J Stengel Peter
Shakya Sagar
Remarchuk Travis
Original Assignee
Array Biopharma Inc
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Array Biopharma Inc, Genentech Inc filed Critical Array Biopharma Inc
Publication of BR112014028589A2 publication Critical patent/BR112014028589A2/pt
Publication of BR112014028589B1 publication Critical patent/BR112014028589B1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
BR112014028589-6A 2012-05-17 2013-05-17 Ciclopentilpirimidina hidroxilada, seu processo de fabricação e seus intermediários BR112014028589B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261648473P 2012-05-17 2012-05-17
US61/648,473 2012-05-17
US201361785122P 2013-03-14 2013-03-14
US61/785,122 2013-03-14
PCT/US2013/041666 WO2013173768A1 (en) 2012-05-17 2013-05-17 Process for making hydroxylated cyclopentylpyrimidine compounds

Publications (2)

Publication Number Publication Date
BR112014028589A2 true BR112014028589A2 (pt) 2017-07-25
BR112014028589B1 BR112014028589B1 (pt) 2022-08-23

Family

ID=48485537

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014028589-6A BR112014028589B1 (pt) 2012-05-17 2013-05-17 Ciclopentilpirimidina hidroxilada, seu processo de fabricação e seus intermediários

Country Status (21)

Country Link
US (4) US9416110B2 (pt)
EP (1) EP2861582B1 (pt)
JP (1) JP6284928B2 (pt)
KR (1) KR102067850B1 (pt)
CN (1) CN104470913B (pt)
AU (1) AU2013262505B2 (pt)
BR (1) BR112014028589B1 (pt)
CA (1) CA2873654C (pt)
DK (1) DK2861582T3 (pt)
ES (1) ES2582557T3 (pt)
HK (1) HK1208451A1 (pt)
IL (1) IL235715A (pt)
MX (1) MX353384B (pt)
MY (1) MY169028A (pt)
NZ (1) NZ702935A (pt)
PL (1) PL2861582T3 (pt)
RU (1) RU2643811C2 (pt)
SG (1) SG11201407616TA (pt)
SI (1) SI2861582T1 (pt)
WO (1) WO2013173768A1 (pt)
ZA (1) ZA201409261B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY169028A (en) 2012-05-17 2019-02-04 Genentech Inc Process for making hydroxylated cyclopentylpyrimidine compounds
RU2642311C2 (ru) 2012-05-17 2018-01-24 Дженентек, Инк. Способ получения гидроксилированных циклопентапиримидиновых соединений и их солей
DK2858989T3 (da) 2012-05-17 2020-06-02 Genentech Inc Amorf form af en AKT-hæmmende pyrimidinyl-cyclopentan-forbindelse, sammensætninger deraf og fremgangsmåder dertil
BR112014028570A2 (pt) 2012-05-17 2018-04-24 Array Biopharma Inc processo para fabricação de compostos de ciclopentilpirimidina hidroxilada.
BR112016011048A8 (pt) * 2013-11-15 2020-04-22 Hoffmann La Roche processo para preparar um composto, processos para fabricar compostos, compostos e composições farmacêuticas
RU2732404C2 (ru) * 2014-09-26 2020-09-16 Ф. Хоффманн-Ля Рош Аг СПОСОБЫ ПОЛУЧЕНИЯ (ЦИКЛОПЕНТИЛ[d]ПИРИМИДИН-4-ИЛ)ПИПЕРАЗИНОВЫХ СОЕДИНЕНИЙ
EP3496722A1 (en) 2016-08-10 2019-06-19 H. Hoffnabb-La Roche Ag Pharmaceutical compositions comprising akt protein kinase inhibitors
KR20230011368A (ko) 2020-06-16 2023-01-20 에프. 호프만-라 로슈 아게 하이드록실화 사이클로펜틸피리미딘 화합물 제조 방법
KR20230035773A (ko) * 2021-09-06 2023-03-14 연세대학교 산학협력단 Akt 신호경로 억제제를 유효성분으로 포함하는 아토피피부염의 예방 또는 치료용 조성물

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9408197A (pt) 1993-12-12 1997-08-26 Agrogene Ltd Método para proteger plantas contra doenças fúngicas
EP0973396A4 (en) 1997-04-07 2001-02-07 Merck & Co Inc METHOD FOR TREATING CANCER
US6201023B1 (en) 1997-06-10 2001-03-13 Agrogene Ltd. Methods and compositions to protect crops against plant parasitic nematodes
EP0982300A3 (en) 1998-07-29 2000-03-08 Societe Civile Bioprojet Non-imidazole alkylamines as histamine H3 - receptor ligands and their therapeutic applications
WO2000052134A2 (en) 1999-03-03 2000-09-08 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
EP1188754B1 (en) * 1999-06-03 2005-06-01 Teikoku Hormone Mfg. Co., Ltd. Substituted pyrazole compounds
AU7715300A (en) 1999-09-27 2001-04-30 Merck & Co., Inc. Method of preventing osteoporosis
US7582766B2 (en) 2003-06-09 2009-09-01 Boehringer Ingelheim International Gmbh Inhibitors of papilloma virus
US8927546B2 (en) 2006-02-28 2015-01-06 Dart Neuroscience (Cayman) Ltd. Therapeutic piperazines
US8063050B2 (en) * 2006-07-06 2011-11-22 Array Biopharma Inc. Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
UA95641C2 (en) * 2006-07-06 2011-08-25 Эррей Биофарма Инк. Hydroxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors
US20100298289A1 (en) 2007-10-09 2010-11-25 Ucb Pharma, S.A. Heterobicyclic compounds as histamine h4-receptor antagonists
WO2010120935A1 (en) 2009-04-15 2010-10-21 Abbott Laboratories Anti-viral compounds
ES2465094T3 (es) * 2009-10-23 2014-06-05 Eli Lilly And Company Inhibidores de AKT
US9050334B2 (en) 2010-07-16 2015-06-09 Innov88 Llc MIF inhibitors and their uses
WO2012177925A1 (en) 2011-06-21 2012-12-27 The Board Institute, Inc. Akt inhibitors for treating cancer expressing a magi3 - akt3 fusion gene
MX350443B (es) 2012-05-17 2017-09-06 Genentech Inc Proceso para hacer compuestos de aminoácidos.
RU2642311C2 (ru) 2012-05-17 2018-01-24 Дженентек, Инк. Способ получения гидроксилированных циклопентапиримидиновых соединений и их солей
DK2858989T3 (da) 2012-05-17 2020-06-02 Genentech Inc Amorf form af en AKT-hæmmende pyrimidinyl-cyclopentan-forbindelse, sammensætninger deraf og fremgangsmåder dertil
BR112014028570A2 (pt) 2012-05-17 2018-04-24 Array Biopharma Inc processo para fabricação de compostos de ciclopentilpirimidina hidroxilada.
MY169028A (en) 2012-05-17 2019-02-04 Genentech Inc Process for making hydroxylated cyclopentylpyrimidine compounds
US20140121193A1 (en) 2012-11-01 2014-05-01 Robert S. Katz Methods for treating fibromyalgia
CN105263910A (zh) 2013-02-18 2016-01-20 斯克利普斯研究所 具有治疗潜力的血管加压素受体调节剂
CA2904662A1 (en) 2013-03-15 2014-09-25 Shifa Biomedical Corporation Anti-pcsk9 compounds and methods for the treatment and/or prevention of cardiovascular diseases

Also Published As

Publication number Publication date
US9676730B2 (en) 2017-06-13
US20160318877A1 (en) 2016-11-03
MX353384B (es) 2018-01-10
SG11201407616TA (en) 2015-03-30
BR112014028589B1 (pt) 2022-08-23
US20170247337A1 (en) 2017-08-31
MX2014013862A (es) 2015-05-07
JP6284928B2 (ja) 2018-02-28
WO2013173768A1 (en) 2013-11-21
IL235715A0 (en) 2015-02-01
RU2014151050A (ru) 2016-07-10
MY169028A (en) 2019-02-04
IL235715A (en) 2017-02-28
EP2861582B1 (en) 2016-05-25
DK2861582T3 (en) 2016-08-22
AU2013262505B2 (en) 2017-09-21
CA2873654C (en) 2021-06-22
CA2873654A1 (en) 2013-11-21
HK1208451A1 (en) 2016-03-04
CN104470913B (zh) 2018-07-20
ZA201409261B (en) 2017-05-31
KR20150020214A (ko) 2015-02-25
US20150152067A1 (en) 2015-06-04
EP2861582A1 (en) 2015-04-22
KR102067850B1 (ko) 2020-01-17
JP2015517532A (ja) 2015-06-22
RU2643811C2 (ru) 2018-02-06
US9416110B2 (en) 2016-08-16
PL2861582T3 (pl) 2016-11-30
ES2582557T3 (es) 2016-09-13
NZ702935A (en) 2017-02-24
CN104470913A (zh) 2015-03-25
SI2861582T1 (sl) 2016-09-30
US20180258054A1 (en) 2018-09-13
AU2013262505A1 (en) 2015-01-22
US9790190B2 (en) 2017-10-17

Similar Documents

Publication Publication Date Title
BR112014005322A2 (pt) processo
BR112014012414A2 (pt) processo para a preparação de 5-flúor-1h-pirazolopiridinas substituídas
BR112014016000A8 (pt) processo
BR112014008196A2 (pt) processo para a preparação de um composto
BR112014028589A2 (pt) processo para fabricação de compostos de ciclopentilpirimidina hidroxilada
BR112014004622A8 (pt) processo para a preparação de isocianatos
BR112014026796A2 (pt) processo
BR112014028570A2 (pt) processo para fabricação de compostos de ciclopentilpirimidina hidroxilada.
BR112014012243A2 (pt) processo de preparação de compostos
BR112013030423A2 (pt) método para produção de biocoque
BR112014016001A2 (pt) processo
BR112013008883A2 (pt) processo para a fabricação de di-hidropteridinonas
BR112015003101A2 (pt) processo para a preparação de um composto.
BR112015002912A2 (pt) processo para a produção de benzoxazinonas
BR112014015988A8 (pt) processo
BR112013033184A2 (pt) processo
BR112014010997A2 (pt) processo para o preparo de ß-glicosídeos de c-arila
BR112014015999A8 (pt) processo
BR112013022548A2 (pt) processo para a preparação de aminas primárias
BR112015000987A2 (pt) processo para a preparação de 5-fluoro-1h-pirazóis
BR112014028585A2 (pt) processo para fabricação de compostos de aminoácido.
BR112014014052A2 (pt) processo para a preparação de 5-hidroximetilfurfural
BR112014010327A2 (pt) processo para a preparação de compostos
BR112014015512A8 (pt) processo para a preparação de um composto
BR112014017215A8 (pt) método para a produção de um produto químico

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B15K Others concerning applications: alteration of classification

Free format text: A CLASSIFICACAO ANTERIOR ERA: C07D 403/04

Ipc: C07D 403/04 (2006.01), C07D 239/70 (2006.01), C07D

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 17/05/2013, OBSERVADAS AS CONDICOES LEGAIS